Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Shaun Bender"'
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1291-1302 (2024)
Abstract Introduction This post hoc analysis of VOLTAIRE-RA compared patient-reported outcomes, including health-related quality of life (HRQoL), in patients with rheumatoid arthritis (RA) before and after treatment with biosimilar adalimumab-adbm or
Externí odkaz:
https://doaj.org/article/7e4f06b43dc942acaaaa3dceaef99827
Autor:
Marco Luigetti, Dianna Quan, John L. Berk, Isabel Conceição, Yohei Misumi, Chi-Chao Chao, Shaun Bender, Emre Aldinc, John Vest, David Adams
Publikováno v:
Neurology and Therapy, Vol 13, Iss 3, Pp 625-639 (2024)
Abstract Introduction Hereditary transthyretin (ATTRv, v for variant) amyloidosis is a rare, progressive, fatal disease with multisystem manifestations, caused by pathogenic variants in the transthyretin (TTR) gene. Vutrisiran, an RNA interference th
Externí odkaz:
https://doaj.org/article/60ae68c6fd63459e8e8e5e819c0f290b
Autor:
Megan L Neely, Anne S Hellkamp, Shaun Bender, Jamie L Todd, Timothy Liesching, Tracy R Luckhardt, Justin M Oldham, Rishi Raj, Eric S White, Scott M Palmer
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease characterised by decline in lung function. We evaluated trajectories of forced vital capacity (FVC) and diffusing capacity (DLco) in a cohort
Externí odkaz:
https://doaj.org/article/7eec8ee325ea47e999553190ed708c3e
Autor:
Todd L. Astor, Hilary J. Goldberg, Laurie D. Snyder, Andrew Courtwright, Ramsey Hachem, Tahuanty Pena, Lorenzo Zaffiri, Gerard J. Criner, Marie M. Budev, Tany Thaniyavarn, Thomas B. Leonard, Shaun Bender, Aliaa Barakat, Janis L. Breeze, Peter LaCamera
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 17 (2023)
Background: It is unclear whether continuing anti-fibrotic therapy until the time of lung transplant increases the risk of complications in patients with idiopathic pulmonary fibrosis. Objectives: To investigate whether the time between discontinuati
Externí odkaz:
https://doaj.org/article/166e744374eb43c283b130537cffc784
Autor:
Joao A. de Andrade, Tejaswini Kulkarni, Megan L. Neely, Anne S. Hellkamp, Amy Hajari Case, Daniel A. Culver, Kalpalatha Guntupalli, Shaun Bender, Craig S. Conoscenti, Laurie D. Snyder, the IPF-PRO Registry Investigators
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Performance benchmarks for the management of idiopathic pulmonary fibrosis (IPF) have not been established. We used data from the IPF-PRO Registry, an observational registry of patients with IPF managed at sites across the US, to
Externí odkaz:
https://doaj.org/article/d9cb1522f4b141099d73e79e8b59d74e
Autor:
Hyun J. Kim, Laurie D. Snyder, Ayodeji Adegunsoye, Megan L. Neely, Shaun Bender, Eric S. White, Craig S. Conoscenti, Mary E. Strek, The IPF-PRO Registry Investigators
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Hospitalizations are common among patients with idiopathic pulmonary fibrosis (IPF). We investigated the impact of hospitalizations on outcomes in patients with IPF. Methods The IPF-PRO Registry is an observational US registry tha
Externí odkaz:
https://doaj.org/article/14977bb188b74aeda3d88b1022eb8c36
Autor:
Glenwood D. Goss, Manuel Cobo, Shun Lu, Konstantinos Syrigos, Ki Hyeong Lee, Erdem Göker, Vassilis Georgoulias, Dolores Isla, Alessandro Morabito, Young J. Min, Andrea Ardizzoni, Shaun Bender, Agnieszka Cseh, Enriqueta Felip
Publikováno v:
EClinicalMedicine, Vol 37, Iss , Pp 100940- (2021)
Background: LUX-Lung 8 was a randomised, controlled, phase 3 study comparing afatinib and erlotinib as second-line treatment of patients with advanced squamous cell carcinoma (SCC) of the lung. We report the final overall survival (OS) and safety ana
Externí odkaz:
https://doaj.org/article/d8fe0d7fea454b01b8c9f6bcd8ec32f9
Autor:
Laurie Snyder, Megan L. Neely, Anne S. Hellkamp, Emily O’Brien, Joao de Andrade, Craig S. Conoscenti, Thomas Leonard, Shaun Bender, Mridu Gulati, Daniel A. Culver, Robert J. Kaner, Scott Palmer, Hyun Joo Kim, on behalf of the IPF-PRO™ Registry investigators
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease with a variable clinical course and high mortality. We used data from a large national US registry of patients with IPF to investigate relationships between patient char
Externí odkaz:
https://doaj.org/article/220745ba1bec4eea82f942d3f9caea4e
Autor:
Craig S Conoscenti, Lisa H Lancaster, Imre Noth, Laurie D Snyder, Christopher Mosher, Colin H Holtze, Kevin R Flaherty, Megan L Neely, Anne S Hellkamp, Shaun Bender, Joao A de Andrade, Timothy PM Whelan
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease with high mortality. Patient characteristics associated with diagnostic delays are not well described.Methods Subjects who had not been diagnosed with IPF prior to referral and r
Externí odkaz:
https://doaj.org/article/8bf325044cfc47efbae127847fe7a8db
Autor:
Joao A. de Andrade, Megan L. Neely, Anne S. Hellkamp, Daniel A. Culver, Hyun J. Kim, Timothy Liesching, Leonard J. Lobo, Murali Ramaswamy, Zeenat Safdar, Shaun Bender, Craig S. Conoscenti, Thomas B. Leonard, Scott M. Palmer, Laurie D. Snyder
Publikováno v:
Clinical Therapeutics. 45:306-315